The analyses and visuals on this site are for informational purposes only and do not constitute investment advice.

© 2026 Datafin Financial Data Analysis Systems. All rights reserved. · v2.0

Privacy PolicyTerms of UseCookie Policy

EBS FINANCIAL STATEMENTS

Emergent Biosolutions Inc — balance sheet, income statement and cash flow trends

EBSEmergent Biosolutions Inc

🇺🇸 USA · NYSE · Healthcare · Drug Manufacturers - Specialty & Generic

Value itDuel
PriceFinancialsPeers

Income Statement

Quarterly progression — trailing-twelve-month values
RevenueNet Income to Owners
01 B2020202120222023202420252026

Profit Funnel

Q2 2026 · TTM
Revenue535.9 M $Gross Profit243.3 M $ · 45%Operating Income70.7 M $ · 13%Pre-tax Income20.3 M $ · 4%Net Income to Owners3.4 M $ · 1%

Percentages are relative to revenue.

Key Figures

YoY change
Revenue535.9 M $-37.1%
Gross Profit243.3 M $-48.7%
Operating Income70.7 M $-32.1%
EBITDA132.6 M $-51.6%
Net Income to Owners3.4 M $-97.6%

No peer data is available for this stock.

Balance Sheet

Quarterly period-end values
Total AssetsTotal LiabilitiesEquity
01 B2 B3 B2020202120222023202420252026

Capital Structure

Q2 2026
Total Assets1.1 B
  • Equity341.4 M $31%
  • Current Liabilities122.8 M $11%
  • Long-term Liabilities652.6 M $58%

Key Figures

YoY change
Total Assets1.1 B $-21.2%
Total Liabilities775.4 M $-12.0%
Total Equity341.4 M $-36.3%
Cash & ST Investments139.7 M $-48.5%
Total Debt581.8 M $-13.9%
Net Debt442.1 M $+9.1%

No peer data is available for this stock.

Cash Flow Statement

Quarterly progression — trailing-twelve-month values
Operating Cash FlowCapital ExpendituresFree Cash Flow
-250 M0250 M500 M2020202120222023202420252026

Cash Flow Bridge

Q2 2026 · TTM
-100 M-50 M041.6 M $Operating-9.7 M $Investing-141.2 M $Financing-109.3 M $Net Change

Key Figures

YoY change
Operating Cash Flow41.6 M $-75.4%
Capital Expenditures9.7 M $-30.7%
Free Cash Flow31.9 M $-79.4%
Dividends Paid——

No peer data is available for this stock.

Amounts are in the company’s reporting currency. Peer comparison tables use ratio-based metrics so currency differences do not distort the picture.

Go deeper on EBS

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Sep 3, 26. This content is for informational purposes only and is not investment advice.